• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form PX14A6G filed by Centene Corporation

    4/11/25 2:27:04 PM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email
    PX14A6G 1 i411251px14a6g.htm

     

     

     

     

     

    Notice of Exempt Solicitation Pursuant to Rule 14a-103

    Name of Registrant: Centene Corporation (CNC)

    Name of person relying on exemption: John Chevedden, Centene Shareholder since 2019

    Address of persons relying on exemption: POB 2673, Redondo Beach, CA 90278

     

    These written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securities Exchange Act of 1934. John Chevedden does not beneficially own more than $5 million of the class of subject securities, and this notice of exempt solicitation is therefore being provided on a voluntary basis.

     

    This is not a solicitation of authority to vote your proxy.

     

    Please DO NOT send me your proxy card; the shareholder is not able to vote your proxies, nor does this communication contemplate such an event.

     

    The shareholder asks all shareholders to vote by following the procedural instructions provided in the proxy materials. 

     

     

     

    Please Support Item #5 to Disclose Plan to Reduce Total Contribution to Climate Change

     

    To Centene Shareholders:

     

    I ask shareholders to vote FOR Item 5 at the Centene shareholder meeting on May 13, 2025. The proposal asks Centene (“the Company”) to disclose a report on its plans for reducing its contribution to climate change:

     

    RESOLVED: Shareholders request that Centene issue a report (at reasonable cost, omitting proprietary information) describing if, and how, it plans to reduce its total contribution to climate change and align its operations and investments with the Paris Agreement’s ambition of limiting global temperature rise.

     

    SUPPORTING STATEMENT: In the report shareholders seek information, at board and management discretion, on the relative benefits and drawbacks of integrating the following actions:

     

    ·Adopting science-based GHG emission reduction targets for the Company's full range of operational and value chain emissions, taking into consideration criteria used by advisory groups like the Science Based Targets initiative;

     

      
     

     

    ·Developing a transition plan that shows how the Company plans to meet its goals, taking into consideration criteria used by advisory groups such as the Transition Plan Taskforce, Task Force for Climate-Related Financial Disclosures, CDP, Climate Action 100+, and Ceres; and
    ·Adopting supporting targets for renewable energy, energy efficiency, supply chain engagement, or other measures deemed appropriate by management.

     

    1.Centene acknowledges that climate change poses risks to its business.

     

    In order to limit warming to 1.5 °C and prevent the worst impacts of climate change, emissions must be cut in half by 2030 and reach net zero by 2050. Rising temperatures associated with climate change not only increase the frequency of extreme weather events, which may pose physical risks to Centene’s operations, but also exacerbate health hazards by worsening air quality,1 augmenting heat-related illnesses,2 and spreading vector-borne diseases.3 Centene has analyzed various climate drivers and identified a myriad of negative health outcomes that may arise from them, which could impact the Company’s margins as global temperatures continue to increase.4 Indeed, Centene notes in its most recent 10-K that the effects of climate change “could reduce our ability to accurately predict and effectively control the costs of providing health benefits.”5 The Company’s opposition statement identifies the “increasing regulatory and political uncertainty regarding disclosure and management of climate-related risks” as a reason to vote against this proposal. However, these changing dynamics do not affect the imperative to mitigate the material financial risks that climate change poses to Centene’s business, investor portfolios, and the global economy.

     

    2.Centene does not have a long-term climate mitigation strategy aligned with the Paris Agreement’s ambition to limit warming to 1.5 °C, and this proposal provides the Company with flexibility in its approach.

     

    While Centene’s emissions reduction efforts to date are commendable, the Company has not set targets for continuing progress in the near term or reaching net zero in the long term. Setting forward-looking goals is especially relevant as a large portion of the Company’s scope 1 and 2 reductions appear to have resulted from its reduced real estate footprint. While this created reductions in the Company’s emissions accounting, it is unclear whether Centene’s emissions have declined per square foot across its remaining real estate footprint or whether this action translated to fewer real-world emissions. Furthermore, over 80% of Centene’s emissions fall into scope 3, purchased goods and services, for which the Company has not described any efforts to reduce its supply chain emissions. Additional progress may require actions such as renewable energy procurement and supply chain engagement, which require careful planning and dedication of resources. Both these actions could, as examples, result in lower energy costs, increased resilience, and strengthened supplier relationships for the Company.

    _____________________________

    1 https://www.epa.gov/climateimpacts/climate-change-impacts-air-quality

    2 https://www.nejm.org/doi/full/10.1056/NEJMra2210769

    3 https://www.cdc.gov/climate-health/php/effects/vectors.html

    4 https://www.centene.com/content/dam/centenedotcom/documents/TCFD-Index-2024.pdf

    5 https://www.sec.gov/ix?doc=/Archives/edgar/data/1071739/000107173924000037/cnc-20231231.htm

     

      
     

     

     

    The proponent supports the Company’s desire to maintain “flexibility to choose from among appropriate sustainability initiatives and the timing for the implementation of those initiatives," as expressed in the opposition statement. This proposal does not seek to prescribe specific emissions reduction strategies or impose a particular timeline for setting targets, providing latitude to the Company regarding implementation. Rather, the proposal seeks a report to understand if, and how, Centene will continue to reduce its climate impacts and mitigate associated risks going forward.

     

    3.The Company lags peers in setting GHG reduction targets.

     

    Industry peers have high ambitions for GHG reduction. CVS Health (Aetna) and UnitedHealth Group have set and committed to set, respectively, both near-term and net zero targets through the Science Based Targets initiative (SBTi). Cigna also committed to set near-term targets through the SBTi this past summer.6 Elevance Health aims to achieve net zero by 2050 and notes, “we engage our top 80% of suppliers by spend on setting their own science-based emissions reduction targets.” Elevance Health is a signatory to RE100, a corporate renewable energy initiative, and has used 100% renewable energy to power its operations since 2021, 4 years ahead of its 2025 target year.7 The proposal recommends that Centene assess setting targets through the SBTi, which would provide the Company a full two years after making the initial commitment to set targets and identify appropriate strategies to achieve them.

     

     

    Vote “Yes” on Shareholder Proposal #5

     

    _____________________________

    6 https://sciencebasedtargets.org/target-dashboard

    7 https://www.elevancehealth.com/content/dam/elevance-health/documents/ELV_2023_Impact_Report.pdf

     

     

     

     

     

     

    Get the next $CNC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    7/10/2025$33.00Overweight → Equal-Weight
    Morgan Stanley
    7/2/2025$45.00Buy → Neutral
    UBS
    7/2/2025$48.00Overweight → Neutral
    Analyst
    6/9/2025$70.00Overweight
    Morgan Stanley
    6/2/2025$65.00Overweight → Equal Weight
    Barclays
    4/8/2025$64.00Underperform → Hold
    Jefferies
    2/6/2025Buy → Hold
    Argus
    12/17/2024$80.00 → $75.00Overweight
    Analyst
    More analyst ratings

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Burdick Kenneth A was granted 556 shares, increasing direct ownership by 0.15% to 367,053 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      7/2/25 4:59:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Deveydt Wayne S was granted 602 shares, increasing direct ownership by 3% to 19,523 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      7/2/25 4:58:48 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Tanji Kenneth was granted 463 shares, increasing direct ownership by 10% to 5,145 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      7/2/25 4:58:36 PM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    SEC Filings

    See more
    • Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - CENTENE CORP (0001071739) (Filer)

      7/1/25 4:43:52 PM ET
      $CNC
      Medical Specialities
      Health Care
    • SEC Form S-8 filed by Centene Corporation

      S-8 - CENTENE CORP (0001071739) (Filer)

      5/19/25 4:26:30 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - CENTENE CORP (0001071739) (Filer)

      5/14/25 4:09:06 PM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Financials

    Live finance-specific insights

    See more
    • CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS

      -- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total

      4/25/25 6:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care
    • CENTENE CORPORATION TO HOST 2025 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL

      ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors

      3/18/25 4:53:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • CENTENE CORPORATION REPORTS 2024 RESULTS

      -- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 -- 2024 adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.Membership increases of 12% in Marketplace and 50% in Medicare PDP, compared to the fourth quarter of 2023.Executed on capital deployment with $3.0 billion of share repurchases in 2024.Increased 2025 premium and service revenues guidance by $4.0 billion driven by Medicaid revenue and better than expected membership performance during the annual enrollment period in Medicare Advantage and PDP.ST. LOUIS, Feb. 4, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December

      2/4/25 6:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Centene Corporation

      SC 13G - CENTENE CORP (0001071739) (Subject)

      11/14/24 4:06:01 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Centene Corporation

      SC 13G/A - CENTENE CORP (0001071739) (Subject)

      11/13/24 3:02:23 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Centene Corporation

      SC 13G/A - CENTENE CORP (0001071739) (Subject)

      11/12/24 9:55:15 AM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Centene downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Centene from Overweight to Equal-Weight and set a new price target of $33.00

      7/10/25 8:34:38 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene downgraded by Analyst with a new price target

      Analyst downgraded Centene from Overweight to Neutral and set a new price target of $48.00

      7/2/25 7:47:37 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene downgraded by UBS with a new price target

      UBS downgraded Centene from Buy to Neutral and set a new price target of $45.00

      7/2/25 7:47:37 AM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CENTENE CORPORATION WITHDRAWS 2025 GUIDANCE

      ST. LOUIS, July 1, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (Centene, the Company) is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance, including the underlying guidance elements. Marketplace 2025 Risk Adjustment Update The Company recently received and analyzed its first view of 2025 industry Health Insurance Marketplace (Marketplace) data from Wakely, an independent actuarial firm, covering 22 of Centene's 29 Marketplace states, and representing approximately 72% of the Company's Marketplace membership. This data is submitted to Wakely by most Marketplace insurance carriers. Based upon the Company's preliminary interpretation of the data

      7/1/25 4:40:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Health Net Providing Special Assistance to Members and Providers Affected by The Franklin Fire in Malibu Canyon in the City of Malibu, California

      SACRAMENTO, Calif., June 20, 2025 /PRNewswire/ -- Following Gov. Newsom's declaration of a State of Emergency in Malibu Canyon in the City of Malibu, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is taking immediate action to support those affected by the Franklin Fire. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time. Member Prescription Information During a declared State of Emergency, impacted members have tw

      6/20/25 3:18:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Health Net Providing Special Assistance to Members and Providers Affected by Victoria Island Levee Incident in San Joaquin County, California

      SACRAMENTO, Calif., June 2, 2025 /PRNewswire/ -- Following Gov. Newsom's declaration of a State of Emergency in San Joaquin County, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is taking immediate action to support those affected by the Victoria Island Incident. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time. Member Prescription Information During a declared State of Emergency, impacted members have two optio

      6/3/25 11:50:00 AM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      12/19/24 5:39:30 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Dallas H James bought $99,904 worth of shares (1,693 units at $59.01) (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      12/17/24 7:34:06 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Blume Jessica L. bought $14,870 worth of shares (250 units at $59.48) (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      12/17/24 7:33:56 PM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    See more
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

      ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

      2/24/25 4:15:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene Corporation Names First President over Individual Coverage Health Reimbursement Arrangements (ICHRA) Business

      New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan

      1/9/25 9:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care